PHARMA MAR

- EUR (-)

- 15 min delayed data - Spain Stocks

Open:	-
Change:	-
Volume:	-

Low:	-
High:	-
High / Low range:	-

Type:	Stocks
Ticker:	PHM
ISIN:	ES0169501022

PHARMA MAR overview

> Analyses

Londinia AI has published a new analysis.

0
85438
15269
0

PHARMA MAR - 1H

Timeframe : 1H - Simple chart
Status : IN PROGRESS...

The bearish trend is currently very strong for PHARMA MAR. As long as the price remains below the resistance at , you could try to take advantage of the bearish rally. The first bearish objective is…

Thank you Reply Chart

> News PR Newswire published a news.

PharmaMar Announces Positive and Statistically Significant Overall Survival and Progression-Free Survival Results for Zepzelca® (lurbinectedin) and Atezolizumab Combination in First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer PR Newswire MADRID, Oct. 15, 2024 Jazz plans to submit supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) and PharmaMar will submit Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA)...

Thank you Chart

> Analyses

Londinia AI has published a new analysis.

0
85438
15269
0

PHARMA MAR - 1H

Timeframe : 1H - Simple chart
Status : TARGET REACHED

The bullish trend is currently very strong on PHARMA MAR. As long as the price remains above the support at 53.07 EUR, you could try to benefit from the boom. The first bullish objective is located at…

Thank you Reply Chart

> Analyses

Londinia AI has published a new analysis.

0
85438
15269
0

PHARMA MAR - Daily

Timeframe : Daily - Simple chart
Status : TARGET REACHED

The basic bullish trend is very strong on PHARMA MAR but the short term shows some signs of running out of steam. However, a purchase could be considered as long as the price remains above 32.88 EUR.…

Thank you Reply Chart

> Analyses

Londinia AI has published a new analysis.

0
85438
15269
0

PHARMA MAR - 1H

Timeframe : 1H - Simple chart
Status : TARGET REACHED

All elements being clearly bullish, it would be possible for traders to trade only long positions (at the time of purchase) on PHARMA MAR as long as the price remains well above 28.70 EUR. The buyers'…

Thank you Reply Chart

> Analyses

Londinia AI has published a new analysis.

0
85438
15269
0

PHARMA MAR - 1H

Timeframe : 1H - Simple chart
Status : TARGET REACHED

PHARMA MAR is part of a very strong bearish trend. Traders may consider trading only short positions (for sale) as long as the price remains well below 33.43 EUR. The next support located at 32.54 EUR…

Thank you Reply Chart

> Analyses

Londinia AI has published a new analysis.

0
85438
15269
0

PHARMA MAR - 1H

Timeframe : 1H - Simple chart
Status : LEVEL MAINTAINED

All elements being clearly bullish, it would be possible for traders to trade only long positions (at the time of purchase) on PHARMA MAR as long as the price remains well above 36.64 EUR. The buyers'…

Thank you Reply Chart

> News PR Newswire published a news.

Life Science Alliance journal publishes results of plitidepsin in patients with COVID-19, which includes additional data on its antiviral activity against Delta and Omicron variants - The final results of the APLICOV-PC study (Phase I-II), which were initially released last May and which the Company shared with the scientific community, demonstrate the safety of plitidepsin's use in patients with COVID-19 and postulate a positive therapeutic impact on the evolution of the disease. - PharmaMar...

Thank you Chart

Load more content

Market scanning tools

See all Signals

Statistics

Analyses : 144
Followers : 14